Behavioral disorders in kids with autism linked to reduced brain connectivity
More than a quarter of children with autism spectrum disorder are also diagnosed with disruptive behavior disorders. For the first time, Yale researchers have identified a possible biological cause: a key mechanism that regulates emotion functions differently in the brains of the children who exhibit disruptive behavior.
$3.59M NIMH Grant Awarded to Serena Spudich, MD
A new, five-year, $3.59M grant from the National Institute of Mental Health (NIMH) was awarded to Principal Investigator Serena Spudich, MD, Gilbert Glaser Professor of Neurology at Yale, along with co-PI, Joshua Cyktor, PhD, of the University of Pittsburgh.
Bedside point-of-care MRI appears convenient and accurate
In one of the first deployments of a point-of-care MRI scanner, Dr. Kevin Sheth of Yale School of Medicine discussed the application of low-field POC MRI, outlining the constraints of conventional MRI and advantages of MRI at the bedside.Source: AuntMinnie.com
AAN 2021 Virtual Annual Meeting: Highlights
Each year, the American Academy of Neurology (AAN) hosts a meeting wherein neurologists nationwide convene to present on their latest research findings and to learn from their peers. The following members of Yale Neurology presented abstracts at the 2021 virtual annual meeting:
PATHS helps students from underrepresented backgrounds realize med school dreams
Nelson Perez Catalan discovered he was interested in pursuing science while working at a student job at the University of Oregon cleaning glass in the labs. He found himself drawn to research around the brain, and thought about pursuing an MD/PhD, but there was no medical school at his university and as a transplant from Chile, he says much of the U.S. college process was mystifying to him. Then he learned about PATHS, or Program to Advance Training in Health and Sciences at Yale School of Medicine.
CELLO Study to Explore Early Treatment of Multiple Sclerosis
Yale University announced today the initiation of a multicenter study aimed at treating early stage multiple sclerosis (MS). Supported by and in collaboration with Genentech, a member of the Roche Group, the study, known as “CELLO,” will investigate whether short-term treatment with ocrelizumab in patients with MRI lesions consistent with early MS without clinical disease—known as radiologic isolated syndrome—prevents the onset of symptoms.
A new treatment may halt cluster headaches. But some say psychedelic drugs are the real answer.
There are few successful treatment options for cluster headache, a rare, misunderstood, and intensely painful neurologic condition. However, new research suggests that psychedelic drugs may provide relief.Source: The Washington Post
Chronic Headache Disorders & Toxic Exposure: A Policy Panel Discussion
Right now, over 230,000 veterans have joined VA’s Airborne Hazards and Open Burn Pit Registry which documents self-reported health impacts. While much is still unknown, veterans exposed to burn pits report unexplained chronic illnesses, cancers, and respiratory conditions. For many veterans, that means living with debilitating headaches and chronic migraines. Currently, over one million veterans seeking care at VA are diagnosed with a headache disorder and 22 percent of veterans deployed with duties involving burn pits report functional limitations due to migraines. We have a responsibility to care for all those who have borne the battle-- we cannot leave these veterans behind. I’ve made addressing toxic exposure a top priority this Congress, and I am committed to moving forward comprehensive legislation to ensure all of our veterans exposed to toxic substances during their service can access the care and benefits they’ve earned—regardless of where or when they served.Source: Headache & Migraine Policy Forum
National Multiple Sclerosis Society Postdoctoral Fellowship Awarded to Dr. Soumya Yandamuri
Postdoctoral Fellow Dr. Soumya Yandamuri, MSE, PhD has been awarded the National Multiple Sclerosis Society Postdoctoral Fellowship. The grant, “Isolation and characterization of myelin oligodendrocyte glycoprotein monoclonal antibodies,” funds three years and will begin in July 2021.
Wellness Wednesday: Program helps veterans who suffer from chronic headaches
Dr. Jason Sico, the national director for the Veterans Health Administration Headache Center for Excellence, meets with his patients virtually nowadays. “I’ve been doing telehealth for 10 years and it’s been ramped up in earnest during the pandemic,” he said. The program he runs aims to better understand how veterans are suffering. “Trying to get a sense of how many veterans have headaches, what type of headache disorders do they have, what kind of treatments are they getting, do they live in rural areas, urban areas,” Sico added. They then put the data into action, to meet the needs that are out there. “In order to improve something, you have to understand what the baseline is,” he said. “We know traumatic brain injury, the signature injury, can lead to headache. It’s become increasingly important for Congress, as well as the Veterans Health Administration, to understand how many veterans have headaches and how we can do our best to help them.”Source: EyeWitness News 3